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Abstract
PSTPIP1 is a cytoskeleton-associated adaptor protein that links PEST-type phosphatases to their substrates. Mutations in
PSTPIP1 cause PAPA syndrome (Pyogenic sterile Arthritis, Pyoderma gangrenosum, and Acne), an autoinflammatory disease.
PSTPIP1 binds to pyrin and mutations in pyrin result in familial Mediterranean fever (FMF), a related autoinflammatory
disorder. Since disease-associated mutations in PSTPIP1 enhance pyrin binding, PAPA syndrome and FMF are thought to
share a common pathoetiology. The studies outlined here describe several new aspects of PSTPIP1 and pyrin biology. We
document that PSTPIP1, which has homology to membrane-deforming BAR proteins, forms homodimers and generates
membrane-associated filaments in native and transfected cells. An extended FCH (Fes-Cip4 homology) domain in PSTPIP1 is
necessary and sufficient for its self-aggregation. We further show that the PSTPIP1 filament network is dependent upon an
intact tubulin cytoskeleton and that the distribution of this network can be modulated by pyrin, indicating that this is a
dynamic structure. Finally, we demonstrate that pyrin can recruit PSTPIP1 into aggregations (specks) of ASC, another pyrin
binding protein. ASC specks are associated with inflammasome activity. PSTPIP1 molecules with PAPA-associated mutations
are recruited by pyrin to ASC specks with particularly high efficiency, suggesting a unique mechanism underlying the robust
inflammatory phenotype of PAPA syndrome.
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Introduction
The systemic autoinflammatory disorders include a set of
heritable human diseases that are characterized by periodic attacks
of fever, pain, and inflammation in the apparent absence of an
infectious trigger [1]. The most common of these diseases, familial
Mediterranean fever (FMF), is caused by mutations in the MEFV
locus, which encodes the protein pyrin [2,3]. Patients with FMF
suffer sporadic and self-limited episodes of fever, accompanied by
severe, localized pain [4]. Attacks involve massive neutrophil
influx to affected sites, most commonly abdomen (serosal
membranes), chest (pleural membranes) or joint (synovial
membranes). Prophylactic treatment with colchicine, a microtu-
bule toxin, lessens the number and intensity of attacks.
Among identified pyrin-interacting proteins is PSTPIP1 (proline
serine threonine phosphatase-interacting protein 1), a cytosolic
adaptor protein that functions to link PEST phosphatases to their
substrates [5]. Mutations in the PSTPIP1 gene result in PAPA
Syndrome (Pyogenic sterile Arthritis, Pyoderma gangrenosum,
and Acne [6], another autoinflammatory disease with severe skin
and joint involvement. PSTPIP1 mutations have been shown to
increase the binding affinity between PSTPIP1 and pyrin,
suggesting that pyrin and PSTPIP1 are functionally linked in an
unknown pathway connected to inflammation [5].
PSTPIP1 is closely related to PSTPIP2 (also called Mayp, for
macrophage actin-associated tyrosine-phosphorylated protein
[7,8]). Interestingly, human PSTPIP2 maps to chromosome
18q21.3-22, the site of a susceptibility locus for chronic multifocal
osteomyelitis (CRMO), another autoinflammatory disorder that
affects bone and occasionally, skin and bowel [9]. Additionally,
missense mutations in the murine PSTPIP2 gene result in an
osteomyelitis phenotype that is very similar to CRMO [10,11].
Thus, both PSTPIP1 and PSTPIP2 appear to be involved in
inflammatory signaling.
PSTPIP1 and PSTPIP2 share an N-terminal Fer-CIP4
homology (FCH) domain and a central coiled-coil region, through
which they bind to PEST-type phosphatases [12,13]. PSTPIP1,
but not PSTPIP2, also contains a C-terminal SH3 domain that is
important for the binding of several PEST phosphatase substrates,
including c-abl and WASP [8,14]. PSTPIP1, PSTPIP2 and several
related proteins (including FBP-17, CIP4, Toca-1, PACSIN/
syndactin/FAP52 and NOSTRIN) share not only the FCH
domain, but also an extended region containing a coiled coil
downstream of the FCH domain. Proteins with these shared
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BAR) class of the BAR domain superfamily (BAR is named for
Bin-Amphiphysin-Rvs). The BAR domain proteins function to link
cellular membranes to the actin cytoskeleton and are involved in
endocytosis [15].
Recently, it has been proposed that PSTPIP1 homo-trimerizes
via its FCH and coiled-coil domain (F-BAR region) and forms a
functional trimeric complex with pyrin [16]. However, the
recently solved crystalline structures of several related BAR
domain proteins (FCHo2, FBP17 and CIP4), reveal that these
molecules form obligate dimers that are linked in a softly curved
banana shape [17,18]. The ability of these dimers to further
associate into filaments is shared by several members of the F-BAR
family [19,20]. The cellular filaments formed by the PSTPIP1-
related proteins FBP17 and FCHo2 are actually composed of
tubular membrane-associated structures which likely represent
extended endocytotic vesicles that have not undergone scission
[17,19,20,21]. Indeed, the F-BAR domains of both PSTPIP1 and
PSTPIP2 can bind to artificial liposomes containing phosphatidyl
inositol (4,5) bisphosphate (PI(4,5)P2) with high affinity [19].
Furthermore, binding induces tubulation of these liposomes in
vitro [19].
In this report, we confirm that cytosolic filamentous structures
formed by the PSTPIP1 protein are membrane associated and we
identify the minimal domains of PSTPIP1 that are required to
form these filamentous elements. We present biochemical and
molecular modeling evidence that PSTPIP1 exists as a dimer and
predict a cohesive pyrin-binding interface. In addition, we explore
the connection between PSTPIP1 filaments and the cellular
cytoskeleton and demonstrate that pyrin binding affects PSTPIP1
filament distribution. Finally, we examine the binding relation-
ships between PSTPIP1, pyrin, and the pyrin-binding protein
ASC. The results of these analyses suggest a revised model of
pyrin/PSTPIP interaction in the context of inflammatory disease.
Materials and Methods
Plasmids and Antibodies
All FLAG-tagged constructs were cloned into pCMV-Tag2B
and myc-tagged constructs were generated using pCMV-Tag3A
(both from Stratagene, La Jolla, CA). The pHIS8 plasmid used for
expression of PSTPIP1 in E. coli was previously described [22]. A
QuikChange II Site-directed Mutagenesis Kit (Stratagene, La
Jolla, CA) was used to generate PSTPIP1 and pyrin mutants.
Fluorescent labeled constructs were expressed using pEYFP-C1
and pEGFP-C2 vectors from Clontech (Mountain View, CA).
Anti-myc (rabbit polyclonal) and anti-FLAG, anti-tubulin, and
anti-vimentin (all mouse monoclonal) antibodies were obtained
from Sigma (St. Louis, MO). Actin filaments were visualized using
AlexaFluor488 Phalloidin from Molecular Probes by Invitrogen
(Eugene, OR). Fluorescent-labeled secondary antibodies (Alexa-
Fluor488 goat anti-mouse and AlexaFluor568 goat anti-rabbit)
were also obtained from Molecular Probes by Invitrogen (Eugene,
OR). The PSTPIP1 (anti-CD2BP1) antibody 8C93D8 used for
immunofluorescence studies [23] and the anti-human PSTPIP1
used for Western blotting[5] were previously described.
Cell Culture and Transfection
COS-7 and HeLa cells were grown in DMEM (Gibco by
Invitrogen, Carlsbad, CA) supplemented with 10% FBS (vol/
vol). Cells were transfected using FUGENE-6 (Roche Applied
Science, Indianapolis, IN). Cells were fixed 24–36 hours after
transfection.
Isolation of human cells
Human blood was collected from healthy volunteers (IRB#
1992-0480) and mixed with an anti-coagulation solution contain-
ing 0.14 M anhydrous citric acid, 0.20 M citric acid trisodium salt,
and 0.22 M dextrose. Red blood cells were sedimented by
addition of 6% dextran and incubation for 30–45 minutes at
room temperatures. The upper, leukocyte-rich layer was removed
and remaining red blood cells were destroyed by hypotonic lysis in
distilled water. Leukocytes were concentrated by centrifugation,
and layered onto Ficoll/Paque (Pharmacia, Uppsala, Sweden)
density gradient. Following centrifugation of the gradient, the
neutrophil layer was removed, fixed, and stained. The monocyte/
lymphocyte layer was removed, and monocytes were enriched by
cell adhesion. Non-adherent lymphocytes were washed off
24 hours later, and the adherent monocytes were fixed and
stained. To generate CD14+ lysates for Western blotting, CD14+
cells were enriched from PBMC populations using magnetic
separation (Miltenyi).
Immunofluorescence
Cells were fixed for 30 minutes in a 4% parafomaldehyde
solution in PBS. After permeablization in 0.2% Triton-X in PBS
for 10 minutes, cells were exposed to blocking solution (10% goat
serum, 1% BSA, and 0.1% Tween-20 in PBS) for 1 hour. After
antibody staining, 10 mM DAPI was applied to the cells for 1
minute for nuclear visualization. Coverslips were mounted with
ProLong Gold Anti-Fade Reagent (Molecular Probes by Invitro-
gen, Eugene, OR). Slides were visualized using a Nikon E800
fluorescence microscope.
Nocodazole Assays
Twenty-four hours after being transfected with PSTPIP1, HeLa
cells were treated with 4.15 mM nocodazole and incubated on ice
for 10 minutes to depolymerize microtubules. Cells were then
rinsed 3 times in media and observed at 37uC in order to watch
microtubules re-form.
Cytochalasin-D Assays
A 2 mM stock of cytochalasin D was prepared in chloroform. At
the time of experiment this stock solution was diluted in cell
culture medium to a working concentration of 10 mM. Cells were
treated for 30 minutes and then fixed with 4% paraformaldehyde
in PBS.
DiIC16 Membrane Staining
The DiIC16 membrane staining protocol was performed as
previously described [21]. Twenty-four hours after COS-7 cells
were transfected, cells were washed three times with DMEM
without phenol red. DiIC16 (Invitrogen, Carlsbad, CA) was diluted
to a concentration of 1.0 mg/mL in DMSO, then further diluted
to 1 mg/mL in DMEM without phenol red. DiIC16 was applied to
the cells, and cells were incubated at 37uC for 10 minutes. Cells
were then rinsed two times in PBS and fixed for 30 minutes in 2%
paraformaldehyde in PBS.
PSTPIP1 structure prediction
A modeled structure of PSTPIP1 as a dimer was generated
based on the structure of FBP17 (pdb accession code 2EFL)
[18] using the program Swiss-Model [24]. Images and
electrostatic properties of the model were generated using an
implementation of APBS [25] in the program PyMOL (http://
www.pymol.org).
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Comparison of PSTPIP1 and Pyrin distribution in native
and transfected cells
PSTPIP1 in human monocytes appears as a branched network
of fine filaments (Figure 1A). In neutrophils, filamentous staining
of PSTPIP1 is suggested, but is less distinct; PSTPIP1 often
appears concentrated on the cell’s edge (Figure 1B). A recent
study confirms that in migrating neutrophils, PSTPIP1 is
polarized in the trailing edge of the uropod, the compartment
that regulates both endocytosis and migration of these cells [26].
In transfected cells, which endogenously express neither pyrin nor
PSTPIP1, transfected PSTPIP1 assembles into delicate filaments
(Figure 1C). As previously reported, expression of PSTPIP1
results in filopodial extension in some transfected cells [27].
Unlike the extensively branched network seen in native
monocytes (Figure 1A), the PSTPIP1 filaments in transfected
cells are relatively straight, and seem to radiate from the nucleus
to the cell periphery. Previous investigators have noted that
PSTPIP1 and PSTPIP2 as well as FBP17 and CIP4 form
filaments in transfected cells [19].
It has been established previously that in human monocytes,
endogenous pyrin is cytosolic while in neutrophils, pyrin is nuclear
[28]. We confirmed those findings and further noted that pyrin in
human monocytes is distributed in a cage-like network of course
filaments that surrounds the nucleus (Figure 1D). In contrast,
when pyrin is transfected into cultured cells, it is uniformly
distributed throughout the cytoplasm without a filamentous
pattern (Figure 1E). It was not possible to simultaneously image
both pyrin and PSTPIP1 in human cells since both primary
antibodies were generated in rabbits.
PSTPIP1 filament formation in transfected cells: lack of
requirement for the SH3 domain and effect of PAPA-
associated mutations
The domains of the PSTPIP1 molecule and their relationship to
PAPA-associated mutations are schematically shown in Figure 2A.
Figure 1. Patterns of pyrin and PSTPIP1 expression in native and transfected cells. (A) Immunostaining of native PSTPIP1 (green) in human
monocytes reveals a finely branched pattern of filaments. (B) In human neutrophils, the PSTPIP1 distribution is filamentous and concentrated at the
edge of the cell. (C) In transfected COS cells, PSTPIP1 forms long straight filamentous structures. (D) In human monocytes, pyrin (red) is distributedi n
a filamentous reticular pattern that extends throughout the cytoplasm and encircles the nucleus. (E) When epitope tagged pyrin (green) is
transfected into COS cells, no reticular network is seen; pyrin is diffusely cytoplasmic.
doi:10.1371/journal.pone.0006147.g001
Pyrin Alters Cellular PSTPIP1
PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6147Figure 2. Identification of the domains of PSTPIP1 that are required for filament formation and filament binding. (A) A schematic view
of the PSTPIP1 molecule (416 amino acids) is shown at top. The F-BAR domain (,300 amino acids) includes the FCH domain, an uncharacterized
intervening region (X) and a coiled coil domain (CC). A short helical region (helix 5) of the F-BAR structure is contained within the 59 end of an
uncharacterized region (Y) downstream of the CC domain [17]. The SH3 domain includes amino acid residues 364–416. The location of three
mutations associated with PAPA syndrome (at amino acids 230, 250 and 266) is shown; a mutation at position 232 abolishes PSTPIP1 binding to pyrin
and to PTP HSCF, a PEST-type protein tyrosine phosphatase (PTP) [5]. The specific deletion constructs tested are outlined in the lower schematic.
Results of these studies are tabulated at right. ‘‘Forms filaments’’ indicates that the protein forms filamentous structures when transfected alone.
‘‘Binds filaments’’ means that the protein binds to formed full length filaments of co-transfected PSTPIP1. (B–J) Truncated versions of myc-tagged
PSTPIP1 shown in (A) were transfected alone or in combination with full-length PSTPIP1-FLAG. B–E) The FCH and coiled-coil portion of PSTPIP1 bound
filaments formed by full-length PSTPIP1 (B–D), but was not able to form filaments when transfected alone (E). (F,G) A PSTPIP protein containing the
coiled-coil and SH3 region of PSTPIP1 was not able to form filaments (not shown), nor was it able to bind to filaments formed by full-length PSTPIP1
(G). (H) PSTPIP1 lacking the SH3 domain forms filaments when transfected alone. Thus, the SH3 domain is not required for filament formation. (I,J) The
two PAPA-associated mutants, A230T (I) and E250Q (J) form long straight filaments similar to those of wildtype PSTPIP1.
doi:10.1371/journal.pone.0006147.g002
Pyrin Alters Cellular PSTPIP1
PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6147To identify the domains of PSTPIP1 that are needed to generate
the characteristic filamentous structures, we transfected COS-7
cells with full-length and/or truncated versions of epitope-tagged
PSTPIP1 (Figure 2A). We tested whether each fragment was able
to form filaments if transfected alone or bind to filaments when co-
transfected with full length PSTPIP1. The individual cells shown
in Figure 2B–J are representative of the most common staining
pattern seen. The F-BAR region, encompassing the FCH and the
CC, was able bind to filaments formed by full-length PSTPIP1
(Figure 2B–D). However, when it was transfected alone, this
fragment did not form filaments (Figure 2E). The C-terminal CC-
Y-SH3 region alone (in the absence of an intact F-BAR domain)
did not form filaments (data not shown) and was unable to bind to
formed filaments when co-transfected with full length PSTPIP1
(Figure 2F–G). However, the FCH-X-CC-Y fragment, lacking
only the SH3 domain, was sufficient to form filaments (Figure 2H).
Thus, though the SH3 domain is dispensable for filament
formation, the remainder of the molecule is required. This result
is fully concordant with previous findings that PSTPIP2, which
lacks the SH3 domain, also forms filamentous structures readily in
cells [19].
All of the known PAPA-causing mutations (A230T, E250Q,
E250K, and D266N) are contained within the region of PSTPIP1
that is important for filament formation. Thus, we tested whether
two of these mutations, A230T and E250Q, alter the ability of
PSTPIP1 to form fibrils. Expression of flag-tagged versions of both
mutant forms of PSTPIP1 resulted in filaments that were similar to
those formed by wild type PSTPIP1 (Figure 2I–J).
PSTPIP1 filaments are dependent on an intact tubulin
cytoskeleton
The organization of PSTPIP1 filaments, with long, straight fibrils
that often appear to radiate from a common origin near the nucleus,
is reminiscent of the orderliness of the tubulin cytoskeleton. Indeed,
the homologous F-BAR domain of CIP4 interacts with microtubules
[14] and the related N-BAR family member, amphiphysin, interacts
with a linker protein (CLIP-170) that binds to microtubules [29].
Thesedatasuggest that thePSTPIP1patternmayarise froma direct
or indirect association with microtubules. We used nocodazole as a
reversible means of depolymerizing microtubules in transfected cells,
and examined filament structure after nocodozole treatment as well
as during recovery induced by nocodozole washout. Destruction of
the tubulin cytoskeleton by nocodozole eliminated PSTPIP1
filaments. However, within one minute post-nocodazole washout,
the microtubules began to rebuild (Figure 3A, B). As the tubulin
structure was restored, a coordinated reconstruction of PSTPIP1
filaments ensued (Figure 3C, D). Both microtubules and PSTPIP1
filaments were almost completely restored by 30 minutes post-
washout (Figure 3E–G) though PSTPIP1 filaments did not precisely
co-localize with microtubules (Figure 3G). Similar results were
obtained in the case of the N-BAR protein, amphiphysin: a
filamentous distribution of amphiphysin was observed in close
proximity to microtubules; these filaments were lost upon nocodo-
zole treatment and regained after nocodozole washout [29].
Intermediate filaments (IF) also depend upon the microtubular
cytoskeleton for proper cellular organization within the cell; thus
IF, or IF-associated proteins may also contribute to the structure of
PSTPIP1 filaments. Indeed, co-staining with vimentin revealed
that PSTPIP1 filaments lie close to IF, but the two proteins do not
directly co-localize (Figure 3H–J).
Pyrin expression alters PSTPIP1 distribution
Pyrin is a known PSTPIP1-interacting protein [5]. The
distribution of pyrin in transfected cells that do not express
PSTPIP1 is diffusely cytoplasmic (Figure 1E), but pyrin exhibits a
course filamentous distribution in human monocytes that express
PSTPIP1 (Figure 1D). Therefore, we tested whether pyrin would
be recruited to PSTPIP1 filaments in cells co-transfected with both
proteins. Indeed, this is the case (Figure 4A–E). Moreover, the
long, relatively straight fibrils characteristic of transfected
PSTPIP1 (Figure 1C) became branched and reticular in the
presence of pyrin (Figure 4A,B). To more easily follow the course
of these filaments in transfected cells, the images were de-
convoluted using image processing software to remove back-
ground noise and enhance the signal from filaments. The
deconvoluted images revealed a network of branching fibrils
extending throughout the cytoplasm and surrounding the nucleus,
with pyrin particularly concentrated at the branch points of the
filaments (Figure 4C–E). Thus, pyrin binds and remodels the
filamentous PSTPIP1 architecture.
Domains of pyrin and PSTPIP1 required for pyrin
recruitment and pyrin-mediated filament redistribution
The binding of PSTPIP1 and pyrin was previously studied by
immunoprecipitation and the SH3 domain of PSTPIP1 was found
to be necessary but not sufficient for this interaction [5].
Additionally, a mutation in the CC region of PSTPIP1, W232A,
abolished PSTPIP1 binding both to pyrin [5] and to the PEST
phosphatase, PTP-HSCF [8]. We therefore examined the effect of
the W232A mutation and the requirement for the SH3 domain on
pyrin’s recruitment to and reticularization of PSTPIP1 filaments.
Figure 4F–H shows that the filaments formed by PSTPIP1(-SH3)
effectively recruited full length pyrin. Furthermore, the pyrin-
decorated PSTPIP1(-SH3) filaments formed a branched, reticular
network similar to that seen with full-length PSTPIP1. Thus, the
SH3 domain is apparently dispensable for the interaction between
pyrin and PSTPIP1. In contrast, the W232A mutation in
PSTPIP1 abolished pyrin binding; consequently, PSTPIP1
filaments were primarily straight, not extensively branched
(Figure 4I–K), confirming that the reticularization of PSTPIP1
filaments is a direct consequence of pyrin binding. Note also that
PSTPIP1 filaments, in the absence of pyrin decoration, are finer
and more delicate in nature (compare Figure 4G to Figure 4J)
We next examined smaller fragments of the pyrin molecule to
determine which regions are required for PSTPIP1 binding and
filament redistribution. Pyrin exon 3 encodes the B-box motif,
while exons 4–5 encode much of the coiled coil (CC) region of
pyrin. Neither of these pyrin fragments bound to PSTPIP1
filaments (Figure 5A–D). Pyrin exons 2–4 produced a protein
capable of aligning with PSTPIP1 filaments, but the PSTPIP1
filament network was not reticularized (Figure 5E–F). Only when
the entire B-box/CC region of pyrin (exons 3–5), was expressed
with PSTPIP1 did we observe a branched PSTPIP1 filament
pattern similar to that induced by full-length pyrin (Figure 5G–I);
pyrin exons 3–5 co-localized with this filamentous PSTPIP1
network.
Mutations in pyrin or PSTPIP1 do not alter the pattern of
PSTPIP1 filaments
It has been proposed that pyrin and PSTPIP1 are functionally
linked in an unknown pathway that is connected to the innate
immune system [5,16]. We therefore tested whether FMF-causing
mutations in pyrin would modulate the interaction between these
two proteins or alter the distribution of PSTPIP1 filaments. Myc-
tagged versions of pyrin mutants were co-transfected with FLAG-
tagged PSTPIP1 in COS-7 cells. We tested pyrin mutations that
are located in exon 2 (E148Q), the B-box region (D330A, P369S),
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B30.2/SPRY domain (V726A, A744S, M680I, M694V, Y688X).
All pyrin mutants bound to PSTPIP1 and reticularized PSTPIP1
filaments in a manner similar to wildtype pyrin (Figure 6A–R).
Similarly, in previous studies using immunoprecipitation, muta-
tions in pyrin did not modify its interaction with PSTPIP1 [5].
To explore the effect of PAPA mutations on the PSTPIP1:pyrin
interaction, we next tested whether the filaments formed by
mutant forms of PSTPIP1 could be reorganized by pyrin. We
found that the PAPA-causing mutations, A230T and E250Q
(Figure 6S–X), were reticularized by pyrin in a manner similar to
that seen with wildtype PSTPIP1. We conclude that disease-
causing mutations in either pyrin or PSTPIP1 do not alter the
basic reticular nature of the pattern seen with co-expression of the
wildtype proteins, though alterations in the function of the
filament system cannot be ruled out.
PSTPIP1 filaments are lipid membrane associated
PSTPIP1 is a member of the F-BAR family of proteins [19].
These proteins are known for their ability to bind to and bend
cellular membranes [30,31], a property that can be revealed by
staining with lipophilic dyes such as DiIC16 [21]. To assess whether
PSTPIP1 filaments are membrane associated, we transfected COS-
7 cells with GFP-tagged PSTPIP1 and then exposed the cells to
DiIC16, a fluorescent lipophilic dye that associates with cellular
membranes. PSTPIP1 filaments co-localized with DiIC16 staining
(Figure 7A–C) as previously described for the related protein,
FBP17[21]. In the presence of pyrin, DiIC16 staining was not
perturbed (Figure 7D–F). Finally, mutations in pyrin (Figure 7G–I)
or in PSTPIP1 (Figure 7J–L) did not affect DiIC16 staining. Taken
together, these data confirm that PSTPIP1 shares the lipid
membrane-binding properties of several other F-BAR domain-
containing proteins, a property that is not affected by pyrin binding.
Figure 3. PSTPIP1 filament structure requires microtubules. Immediately after nocodazole treatment, microtubules are destroyed, as are
PSTPIP1 filaments (not shown). (A–B) Within five minutes of nocodazole removal, microtubules began to rebuild, and PSTPIP1 aggregates are seen.
(C–D) Thirty minutes of nocodazole washout, microtubules are reconstituted and some PSTPIP1 filaments are visible. (E–G) PSTPIP1 filaments align
closely but not exactly with the tubulin cytoskeleton (H–J) PSTPIP1 filaments align next to vimentin filaments, but do not directly overlap these
filaments.
doi:10.1371/journal.pone.0006147.g003
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PLoS ONE | www.plosone.org 6 July 2009 | Volume 4 | Issue 7 | e6147Figure 4. Co-expression of pyrin alters the distribution of PSTPIP1 in transfected cells. (A–E) In cells co-transfected with myc-tagged pyrin
and FLAG-tagged PSTPIP1, PSTPIP1 filaments are branched and reticulated, and pyrin co-localizes with these filaments. (A) and (C) illustrate the
original images, while (B) and (D) are processed images that have been deconvoluted to remove background and enhance the signal of the filaments.
A branched network of filaments surrounding the nucleus is evident. (E) Overlay of pyrin and PSTPIP1 staining pattern after deconvolution; pyrin
appears to be concentrated at the nodes of branch points. (F–H) FLAG-tagged PSTPIP1 lacking the SH3 domain, PSTPIP1(-SH3), can recruit myc-
tagged pyrin to filaments. Pyrin binding causes the filaments to be highly branched or reticular (compare the PSTPIP1 pattern in Figure 4G and
Figure 2H). (I–K) The W232A mutation of PSTPIP1, which cannot bind pyrin, forms straight filaments (green, J), and pyrin (red, I) does not decorate or
reticularize these filaments. The overlay is shown in (K). Note that though filaments appear yellow, there is no filamentous pattern of pyrin (I); rather,
pyrin is uniformly distributed.
doi:10.1371/journal.pone.0006147.g004
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PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6147Figure 5. The B-box/coiled-coil region of pyrin is required for reticularization of PSTPIP1 filaments. Portions of pyrin’s B-box and coiled-
coil region (all myc tagged), were co-transfected with PSTPIP1-FLAG. (A–B) Pyrin exons 2–3 or (C–D) exons 4–5 do not bind PSTPIP1 filaments. Note
that PSTPIP1 filaments (A,C) are generally straight. (E–F) Pyrin exons 2–4 decorates PSTPIP1 filaments, but does not alter their distribution. (G–I) The B-
box and coiled-coil region of pyrin, encoded by exons 3–5, binds to and remodels PSTPIP1 filaments.
doi:10.1371/journal.pone.0006147.g005
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6147Figure 6. FMF-causing mutations do not alter the appearance of reticular PSTPIP1 fibrils; PAPA-associated PSTPIP1 mutants are
bound and reticulated by pyrin. (A–R) Myc-tagged versions of mutant pyrin were co-transfected with PSTPIP1-FLAG: (A–C) P369S; (D–F); E148Q; (G–
I) M694V; (J–L) M680I; (M–O) V726A; (P–R) A744S. (S–X) PAPA syndrome-associated PSTPIP1 were co-transfected myc-pyrin: (S–U) A230T; (V–X) E250Q.
doi:10.1371/journal.pone.0006147.g006
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membrane-interacting and pyrin-interacting surfaces
We generated a model of PSTPIP1 molecular structure, based
on the published structure of the FBP17 dimer [18]. Predicted
PSTPIP1 dimers contained a similar gently curved surface.
Predicted solvent accessible positively charged residues appear
on the concave side (Figure 8A), the region that has been predicted
to interact with the phospholipid membrane. The charge
distribution in the modeled PSTPIP1 molecule is similar to that
seen in other BAR domain proteins [17,18], and implies a similar
mechanism for membrane interaction and filament formation.
We next used the modeled ribbon structure of PSTPIP1 to
predict the location of the PAPA-associated mutations. As shown
in Figure 8B, all three of these amino acid residues (A230, E250
and D266) are located on the convex side of the molecule. This
predicts that these mutations would not alter the ability of the
protein to interact with lipid membranes on its concave surface, a
prediction that is borne out experimentally (see Figure 7). The
model also suggests that the coherent convex binding surface
would likely interact with both pyrin and the PEST phosphatases,
since these PSTPIP1 mutations have been shown to reduce
binding affinity for PEST phosphatases and increase affinity for
pyrin (Shoham, 2005).
Endogenous PSTPIP1 forms dimers
Computer modeling results presented above suggest that
PSTPIP1 exists as a dimer. However, other studies have suggested
that the major form of PSTPIP1 is a trimer [16]. To examine the
state of PSTPIP1 in native cells, we probed Western blots of
CD14+ cell lysates from control individuals and a PAPA syndrome
patient for PSTPIP1 (Figure 8C). In all three cases, the majority of
the PSTPIP1 signal was seen as a 95 kDa species, corresponding
to a PSTPIP1 dimer. A minor species at 48 kDa corresponded to
monomeric PSTPIP1 while faint multimeric forms of PSTPIP1,
likely trimers and tetramers, were also observed. Recombinant
PSTPIP1 protein was also generated and examined in Western
Figure 7. PSTPIP1 filaments are membrane-associated. (A–C) DiIC16 decorates PSTPIP1 filaments, indicating that the fibrils are membrane-
associated. (D–F) In cells transfected with pyrin and PSTPIP1, pyrin produces the typical reticular pattern, and DiIC16 staining is associated with the
branched filaments. (G–I) In cells transfected with pyrin M694V-YFP and wild type PSTPIP1, filaments are visible and stain with DiIC16. (J–L) In cells
transfected with wild type pyrin and PAPA-associated A230T-GFP, DiIC16 filament staining is preserved.
doi:10.1371/journal.pone.0006147.g007
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PLoS ONE | www.plosone.org 10 July 2009 | Volume 4 | Issue 7 | e6147Figure 8. Molecular modeling of PSTPIP1 reveals a banana-shaped dimer and independent coherent binding faces for lipid
membranes and for pyrin. The structure of the PSTPIP1 FCH domain was generated, based on that of FBP17. (A) A space-filled representation of a
PSTPIP1 dimer is presented, with solvent accessible charges highlighted in blue (positively charged) and red (negatively charged). The three
representations present three surfaces, as the dimer is rotated by 90u around the x-axis. A positively charged surface is accessible on the concave
surface of the domain, similar to that seen in FBP17 and FCHo2; this surface has been determined experimentally in those molecules to be the lipid
membrane binding face. (B) In a ribbon diagram of the PSTPIP1 dimer, one molecule is colored green, while the other is blue. Mutations that cause
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unreduced PSTPIP1 protein ran as a dimer as well as a monomer,
only the monomer form was seen in the presence of DTT
(Figure 8D). Taken together, these results indicate PSTPIP1 exists
mainly as a dimer, consistent with the molecular modeling
predictions and consistent with data for related BAR proteins
[17,18].
Interactions among PSTPIP1, ASC and pyrin; effect of
mutations in PSTPIP1 or pyrin
Pyrin can interact with both PSTPIP1 [5] and ASC [32].
Pyrin’s N-terminal pyrin domain facilitates the latter interaction
while pyrin’s B-Box/coiled coil mediates the former. Current
published evidence favors a model of ASC/PSTPIP1/pyrin
interaction in which normally autoinhibited pyrin molecules
require PSTPIP1 mediated unfolding in order to interact with
ASC [16]. If this is the case, then pyrin and ASC should only co-
localize in the presence of PSTPIP1.
To test this model, we transfected cells with various combina-
tions of pyrin, ASC and PSTPIP1. When ASC specks form in cells
transfected with ASC and pyrin, both proteins are always co-
localized in the specks (Figure 9A–D). Thus, pyrin does not require
PSTPIP1 for recruitment to the speck inflammasome compart-
ment. Moreover, in cells transfected with PSTPIP1 and ASC,
PSTPIP1 is never observed in specks (Figure 9E–G), indicating
that PSTPIP1 never visits the inflammasome in the absence of
pyrin. When PSTPIP1, pyrin and ASC are all co-transfected, all
three proteins are co-localized in speck-like structures in 70% of
cells (Figure 9H–J). Thus, pyrin apparently recruits PSTPIP1 to
the speck compartment. In the remaining cells, PSTPIP1 is not
associated with specks (Figure 9K–P). In these latter cases, pyrin is
observed either in association with both specks and PSTPIP1
filaments (Figure 9K–M) or exclusively in ASC specks (Figure 7N–
P). In no case does pyrin decorate PSTPIP1 filaments to the
exclusion of the speck compartment.
We also transfected cells with pyrin-myc, untagged ASC and a
FLAG-tagged version of the W232A PSTPIP1 mutant that does
not bind pyrin. In this case, pyrin is localized in 100% of specks,
but PSTPIP1 is never localized in specks (Figure 9Q–S). Together,
these data establish that pyrin interacts more readily with ASC
than with PSTPIP1 and that recruitment of PSTPIP1 to the speck
compartment is pyrin-dependent. The data do not support a
PSTPIP1-mediated delivery of pyrin to the ASC speck compart-
ment.
When PAPA syndrome-causing mutants of PSTPIP1 were
transfected with ASC and pyrin (A230T Figure 9T–V; E250Q
Figure 9W–Y), PSTPIP1 appeared in the speck with pyrin over
95% of the time (compared to 70% of the time with wild type
PSTPIP1). This corroborates earlier reports that mutant forms of
PSTPIP1 bind to pyrin with higher affinity [5], and confirms that
PSTPIP1 recruitment to the speck compartment depends on the
PSTPIP1-pyrin interaction. Importantly, these data together
indicate that mutant PSTPIP1 is recruited to an inflammasome
compartment (the ASC speck, [33]) with greater efficiency than is
wild type PSTPIP1. In contrast, the use of mutant forms of pyrin
did not alter the frequency of recruitment of PSTPIP1 to the ASC
speck (data not shown), though as shown in earlier studies, mutant
pyrin does increase the rate of speck formation [32,34].
Discussion
The data presented here provide new insight into the biology of
PSTPIP1, the molecule mutated in PAPA syndrome, and clarify
the nature of its interaction with pyrin, the protein mutated in
familial Mediterranean fever. This analysis indicates that an
extended region of the F-BAR domain, but not the SH3 domain,
is necessary for PSTPIP1 filament formation, consistent with
predictions based on the F-BAR structure [18]. Though PSTPIP1
filaments do not appear to co-localize directly with intermediate
filaments or microtubules, we find that the integrity of PSTPIP1
filaments depends on an intact microtubular system. We also
examine the pyrin/PSTPIP1 interaction and show that contrary to
earlier predictions [5], the PSTPIP1 SH3 domain is not required
for its interaction with pyrin. Modeling studies support these
experimental results and predict a coherent surface on the
PSTPIP1 dimer that may interact with pyrin. In support of
modeling studies, PSTPIP1 exists mainly as a dimeric species in
vivo. In the cell, we show that the presence of pyrin alters the
conformation of the PSTPIP1 filamentous network. Finally, we
directly test the binding relationships between PSTPIP1, pyrin,
and the pyrin-binding protein ASC. We find that the balance of
these interactions is altered by disease-causing mutations in
PSTPIP1, but not by FMF-associated mutations in pyrin.
Together, the data predict that the PAPA-associated mutations
may cause an altered cellular distribution of PSTPIP1 in a manner
that has the potential to directly impact inflammatory signaling.
PSTPIP1 is a member of the F-BAR family of proteins, a family
that also includes FCHo2, FBP17 and CIP4, among others
[17,18]. These proteins can bind and tubulate phospholipid
membranes, forming a network of tubular filamentous structures
in the cell. The F-BAR proteins function to couple membrane
deformation to actin cytoskeletal polymerization during endocy-
tosis [19]. We show here that pyrin can not only bind to these
filamentous, PSTPIP-coated membrane tubules, but can also alter
their distribution. It remains to be determined what functional
consequences for the cell accompany this reticularization of the
filamentous pattern (e.g., alterations in endocytosis, phagocytosis,
synapse formation, migration or other processes that involve
membrane deformation). We were not able to discern an effect of
either pyrin mutations or PSTPIP1 mutations on the property of
PSTPIP1 filament reticularization.
Except for the C-terminal SH3 domain, the entire remaining
PSTPIP molecule (FCH-X-CC-Y) is required for filament
formation. In the presence of full length PSTPIP1, the protein
containing only the F-BAR domain (FCH-X-CC) is able to bind to
formed filaments, but the uncharacterized ‘‘Y’’ region between the
coiled coil and the SH3 domain appears to be additionally
required for the generation of filaments (Figure 2). Interestingly,
PAPA syndrome, indicated in three different colors, group together on the convex surface of the molecule. This cohesive face, opposite the
membrane binding face, likely mediates binding interactions with pyrin and PTP-PEST proteins. (C) Western blot CD14+ lymphocyte lysates from
controls (C1, C2) and a PAPA patient (PAPA) in non-reducing conditions, probed with anti-PSTPIP1 reveal a major species at 96 kDa (*), corresponding
to dimerized PSTPIP1. Small amounts of monomer (48 kDA, arrowhead) and multimer (trimer and tetramer, bands at top of gel) are also visible. (D)
Recombinant human PSTPIP1 protein expressed in E. coli is stained with Coomassie reagent. The 98 kDa dimer (*) is prominent when the protein is
run in the absence of reducing agent, while in the presence of DTT, a 48 kDa monomer (arrowhead) is exclusively seen. Since multiple steps in the
recovery of the recombinant protein require addition of DTT, some monomer is present even when additional reducing agent is not added for the
electrophoresis (Lane 1).
doi:10.1371/journal.pone.0006147.g008
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PLoS ONE | www.plosone.org 12 July 2009 | Volume 4 | Issue 7 | e6147Figure 9. Pyrin recruits PSTPIP1 to ASC specks. All images are from transfected COS cells. Representative images are shown. (A) The apoptotic
speck protein, ASC (red), is normally diffusely distributed throughout the cell in cytoplasm and nucleus. (B) ASC (in this case, green) can coalesce into
a small perinuclear aggregate, the speck. (C–D) Pyrin (red) is recruited to ASC specks via its PyD as previously shown [32]. (E–G) PSTPIP1 is not
detected in ASC specks in the absence of co-transfected pyrin. (H–J) In 70% of cells transfected with untagged ASC, PSTPIP1-FLAG and pyrin-myc,
PSTPIP1 is recruited to the speck (arrow, H). (K–P) In 30% of cases, transfection of the three proteins results in localization of pyrin in both PSTPIP1
filaments and in the speck (K–M), or exclusively in the speck (N–P). (Q–S) FLAG-tagged W232A PSTPIP1 does not interact with pyrin, and is not
recruited to specks. (T–Y) Recruitment of PAPA mutants by myc-pyrin to the ASC speck. (T–V) A230T-FLAG. (W–Y) E250Q-FLAG. Pyrin recruits these
mutant forms to ASC specks in 95% of transfected cells.
doi:10.1371/journal.pone.0006147.g009
Pyrin Alters Cellular PSTPIP1
PLoS ONE | www.plosone.org 13 July 2009 | Volume 4 | Issue 7 | e6147Henne et al. noted that, in the crystal structure of FCHo2, an
extended region downstream of the coiled coil forms an alpha
helix (helix 5) that is required for stabilization of the dimers [17].
This region is highly conserved between FCHo2 and PSTPIP1,
and is also clearly present in the homology modeled structure of
PSTPIP1; in fact, it contains residue D266 that is mutated in
PAPA syndrome.
Several F-BAR proteins, including CIP4, FBP17 [18] and
FCHo2 [17], have been crystallized and their structures reveal
important clues about their biological properties. First, it is clear
from these structures that F-BAR proteins exist as dimers that are
molded in a gently curved, banana-like shape. Dimerization is
likely constitutive, since the monomers contain extended dimer-
ization faces that are stabilized by several conserved amino acid
residues [18]. The lesser curvature of the dimer contains a number
of positively charged patches that have been shown to bind to
phospholipids. Alignment of the F-BAR domains of PSTPIP1 and
PSTPIP2 with those of the other F-BAR proteins reveals a high
degree of conservation. Indeed, all of the previously identified
amino acids that function in dimerization are also present in the
two PSTPIP proteins [17,18,35]. Moreover, the positively charged
patches that have been shown to bind to phospholipids are also
conserved [17,18,35] and as we demonstrate here, the PSTPIP1 F-
BAR structure is easily fitted to the established crystal structure of
FBP17. In the model, the PAPA-associated mutations are located
on the outer (lesser curvature) face, in a position that predicts a
coherent pyrin interaction surface. This region might also be a
PEST phosphatase interaction surface, since pyrin and PEST
phosphatase are thought to bind to the same region of PSTPIP1
and the PAPA mutations increase affinity for pyrin while
decreasing affinity for PEST phophatases [5].
Like other F-BAR proteins, we show here that PSTPIP1 is
connected in a dynamic way to both the cytoskeleton and to the
plasma membrane. PSTPIP1 has previously been linked to the
actin cytoskeleton [13], and we report an additional requirement
for the tubulin cytoskeleton in generation of PSTPIP1 filamentous
structure. We found that the PSTPIP1 filament structure is rapidly
regenerated as the microtubular structure is re-built following
nocodozole treatment and washout. The need for intact MT in
endocytosis is well-established [36] and the filamentous mem-
brane-associated tubules generated by PSTPIP1 and other F-BAR
proteins are thought to reflect active endocytosis [37]. Thus, the
rapid re-assembly of PSTPIP1 filaments after nocodozole wash-
out may reflect re-activation of the endocytotic process. It will be
important to determine whether PSTPIP1 binds directly to
microtubules, like the related F-BAR protein, CIP4 [14], or
whether the interaction is via an intermediate microtubule binding
protein, as in the case of amphiphysin [29].
It has been proposed that pyrin and PSTPIP1 are involved in
the same inflammatory signaling pathway and earlier studies
suggest mechanistic pathways for their interaction. First, Shoham
et al. presented a model in which PSTPIP1 binds and sequesters
pyrin and showed that this interaction requires the SH3 domain of
PSTPIP1 [5]. Further, this model posits that sequestration of pyrin
by PSTPIP1 could hamper its ability to interact with, and inhibit,
the ASC inflammasome. Yu, et al. further refined this model,
presenting biochemical evidence that both pyrin and PSTPIP1
exist as homotrimers [16]. The pyrin homotrimer, they propose, is
autoinhibited by the association of its pyrin domain (PyD) with its
own B-box. PSTPIP1, particularly the PAPA-associated mutant
forms of this protein which bind pyrin with high affinity, bind to
pyrin’s B-box, unmasking the PyD and allowing its interaction
with the PyD of ASC. This, in turn, leads to multimerization of
ASC and subsequent recruitment and activation of Caspase-1. In
this model, then, PSTPIP1 is required for pyrin’s functional
interaction with the ASC inflammasome.
Our data suggest a model that differs from these previous
models in three ways. First, our studies show clearly that the SH3
domain of PSTPIP1 is not required for pyrin binding nor is it
necessary for pyrin-mediated reticularization of PSTPIP1 fila-
ments. This difference with previous data may be related to the
difficulty of accurately performing immunoprecipitations with
these proteins, all of which have a high tendency to aggregate,
making redissolution of the immunoprecipitated pellet difficult
[32]. Structural modeling confirms the experimental findings and
suggests a coherent face on the F-BAR region of PSTPIP1 (apart
from the SH3 domain) that could act as a pyrin-interacting and
likely PEST phosphatase-interacting surface. Based on these
findings, it is tempting to speculate that the PSTPIP1-related
protein, PSTPIP2, which lacks an SH3 domain, but also forms
filaments in cells, might also interact with pyrin; PSTPIP2 has
already been shown to interact with PEST phosphatases [8]. This
will be an interesting association to test, since PSTPIP2 is also
linked to inflammatory disease [9,11].
A second difference between our findings and those of earlier
studies is that we find that pyrin is not sequestered away from ASC
by its interaction by PSTPIP1, and does not require PSTPIP1 to
interact with ASC. Rather, pyrin interacts readily with ASC both
in the presence or absence of PSTPIP1. Indeed, in earlier studies,
we demonstrated that, in HeLa cells (which do not express
PSTPIP1) co-transfection of pyrin and ASC promotes ASC speck
formation [32].
Third, and most importantly, in the presence of ASC, pyrin
recruits PSTPIP1 to the ASC speck compartment, a compartment
that PSTPIP1 never visits in the absence of pyrin. Mutant
PSTPIP1, by virtue of its increased binding affinity for pyrin, may
be somewhat more readily recruited to ASC specks than is wild
type PSTPIP1, placing mutant PSTPIP1 more frequently in the
inflammasome compartment. In contrast, we find no evidence that
mutations in pyrin alter the cellular distribution of PSTPIP1 in a
manner that differs from wild type pyrin. Taken together, our data
support the notion that the increased pyrin binding affinity of
PAPA mutations alter the cellular localization of PSTPIP1,
bringing it to a compartment in which it might act to intensify
inflammasome signaling. Indeed, increased inflammasome activity
is implied by the finding that myeloid cells from PAPA syndrome
patients secrete very high quantities of IL-1b [5]. It is interesting to
speculate that a similar model could also apply to the PSTPIP1-
related protein, PSTPIP2. The common structures of the F-BAR
domains of these two PSTPIP proteins [19] and the location of the
likely binding site for pyrin within the F-BAR domain documented
here predict that pyrin may also interact with PSTPIP2. If so, this
might suggest that pyrin, a known regulator of inflammasome
function, is etiologically linked to the pathogenesis of inflammatory
diseases caused by mutant forms of both PSTPIP1 and PSTPIP2.
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